Gastrointestinal Motility Inhibitor [EPC]

Gastrointestinal Motility Inhibitor [EPC] was reported 4235 times

Drugs of the Gastrointestinal Motility Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 MULTIPLE LENTIGINES SYNDROME 15 0.3947
1 PULMONARY VASCULITIS 175 0.3253
2 TOTAL LUNG CAPACITY ABNORMAL 111 0.2853
3 CAPILLARITIS 58 0.2101
4 SPIROMETRY ABNORMAL 109 0.1823
5 MITE ALLERGY 111 0.1695
6 NECROLYTIC MIGRATORY ERYTHEMA 6 0.1538
7 ELECTROCARDIOGRAM U WAVE PRESENT 9 0.1452
8 MYCOTIC ALLERGY 111 0.1298
9 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 94 0.1282
10 NEURITIS 176 0.1139
11 DUST ALLERGY 111 0.1131
12 ADRENAL INSUFFICIENCY NEONATAL 3 0.0882
13 CONJUNCTIVITIS ALLERGIC 114 0.0769
14 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 147 0.0720
15 SOFT TISSUE MASS 32 0.0693
16 RESPIRATORY SYMPTOM 174 0.0611
17 HYPERDYNAMIC LEFT VENTRICLE 11 0.0447
18 CELLULITIS OF MALE EXTERNAL GENITAL ORGAN 5 0.0446
19 FORCED EXPIRATORY VOLUME DECREASED 115 0.0406
20 NECROTISING SOFT TISSUE INFECTION 9 0.0390
21 NORMOCHROMIC NORMOCYTIC ANAEMIA 117 0.0389
22 OESOPHAGEAL PERFORATION 31 0.0372
23 ELECTROCARDIOGRAM P WAVE ABNORMAL 9 0.0367
24 CYTOTOXIC OEDEMA 9 0.0340
25 CSF PRESSURE INCREASED 9 0.0338
26 PULMONARY ALVEOLAR HAEMORRHAGE 177 0.0315
27 DIABETIC RETINAL OEDEMA 16 0.0315
28 NEUROLOGICAL SYMPTOM 176 0.0308
29 VASOPLEGIA SYNDROME 49 0.0299
30 CATARACT SUBCAPSULAR 17 0.0279
31 HYPOGLYCAEMIC SEIZURE 24 0.0264
32 ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED 9 0.0263
33 MULTIMORBIDITY 31 0.0259
34 SHOCK HYPOGLYCAEMIC 12 0.0253
35 EPISCLERITIS 17 0.0246
36 INSULINOMA 4 0.0226
37 SUPERINFECTION 32 0.0213
38 RHINALGIA 56 0.0204
39 GENITAL ABSCESS 8 0.0198
40 NON-CARDIOGENIC PULMONARY OEDEMA 20 0.0189
41 SCROTAL ABSCESS 7 0.0185
42 BLINDNESS CORTICAL 9 0.0184
43 ARTERIOSCLEROSIS CORONARY ARTERY 120 0.0181
44 HYPOGLYCAEMIC UNCONSCIOUSNESS 35 0.0177
45 OBSTRUCTIVE AIRWAYS DISORDER 178 0.0160
46 BRASH SYNDROME 22 0.0157
47 VASCULITIS 175 0.0150
48 RETINAL ISCHAEMIA 9 0.0147
49 FULL BLOOD COUNT ABNORMAL 155 0.0146
50 TINEA INFECTION 16 0.0145
51 HYPOGLYCAEMIA UNAWARENESS 5 0.0140
52 PERINEAL ABSCESS 6 0.0133
53 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 14 0.0132
54 TRANSPLANT FAILURE 32 0.0130
55 LUNG CONSOLIDATION 36 0.0129
56 ARTERIOSCLEROSIS 120 0.0127
57 CARDIAC FAILURE HIGH OUTPUT 3 0.0124
58 FLUID REPLACEMENT 4 0.0118
59 PNEUMONITIS ASPIRATION 4 0.0117
60 ASPARTATE AMINOTRANSFERASE DECREASED 6 0.0113
61 NEPHROGENIC ANAEMIA 52 0.0112
62 ELECTROCARDIOGRAM QRS COMPLEX SHORTENED 4 0.0104
63 NASAL DISCOMFORT 81 0.0102
64 TINEA PEDIS 16 0.0100
65 COLOUR BLINDNESS 9 0.0098
66 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 31 0.0094
67 PULMONARY FIBROSIS 179 0.0093
68 COMPARTMENT SYNDROME 24 0.0092
69 BLOOD OSMOLARITY INCREASED 3 0.0091
70 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 155 0.0091
71 CYSTOID MACULAR OEDEMA 17 0.0090
72 ANAEMIA OF CHRONIC DISEASE 8 0.0088
73 DISTRIBUTIVE SHOCK 20 0.0088
74 NODULE 113 0.0086
75 ACUTE LUNG INJURY 10 0.0084
76 ALANINE AMINOTRANSFERASE DECREASED 6 0.0083
77 COMA SCALE ABNORMAL 24 0.0083
78 DIABETIC RETINOPATHY 28 0.0082
79 DIABETIC GASTROPARESIS 3 0.0082
80 OESOPHAGEAL OBSTRUCTION 7 0.0081
81 HAEMOPTYSIS 224 0.0080
82 ANION GAP 5 0.0079
83 OPTIC NERVE INJURY 9 0.0078
84 EMBOLISM ARTERIAL 9 0.0075
85 ACUTE LEFT VENTRICULAR FAILURE 5 0.0074
86 HYPERPARATHYROIDISM SECONDARY 18 0.0072
87 PANCREATECTOMY 4 0.0072
88 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 39 0.0072
89 PULMONARY VENO-OCCLUSIVE DISEASE 5 0.0071
90 ADMINISTRATION SITE PAIN 8 0.0069
91 CARDIOGENIC SHOCK 97 0.0068
92 INFLAMMATORY MARKER INCREASED 33 0.0067
93 URINE KETONE BODY PRESENT 10 0.0063
94 PERIRECTAL ABSCESS 7 0.0063
95 HYPOGLYCAEMIC COMA 18 0.0062
96 PULSELESS ELECTRICAL ACTIVITY 25 0.0060
97 NODAL ARRHYTHMIA 5 0.0058
98 ENDOCRINE OPHTHALMOPATHY 5 0.0058
99 HYPOPERFUSION 6 0.0057
100 RALES 33 0.0057
101 HYPOGLYCAEMIA 271 0.0056
102 OPTIC ATROPHY 9 0.0055
103 HYPOTHYROIDISM 171 0.0053
104 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 14 0.0053
105 BACTERIURIA 3 0.0053
106 PULSE ABSENT 25 0.0053
107 BEZOAR 7 0.0051
108 HYPOXIA 178 0.0050
109 SINUS PAIN 11 0.0047
110 PSEUDOMONAL BACTERAEMIA 4 0.0047
111 CARDIOACTIVE DRUG LEVEL INCREASED 6 0.0046
112 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 9 0.0046
113 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 10 0.0045
114 ELECTROCARDIOGRAM T WAVE INVERSION 10 0.0045
115 END STAGE RENAL DISEASE 82 0.0045
116 CARDIOMEGALY 53 0.0043
117 NECROTISING FASCIITIS 15 0.0043
118 HYPERVOLAEMIA 21 0.0042
119 GROIN ABSCESS 5 0.0042
120 BLOOD GLUCOSE DECREASED 200 0.0042
121 CHOLANGITIS ACUTE 3 0.0040
122 ELECTROCARDIOGRAM PR PROLONGATION 3 0.0039
123 POLYOMAVIRUS VIRAEMIA 4 0.0038
124 LUNG DISORDER 184 0.0038
125 ANION GAP INCREASED 5 0.0037
126 CARBON DIOXIDE INCREASED 5 0.0037
127 PNEUMONIA STAPHYLOCOCCAL 7 0.0035
128 CARDIAC DYSFUNCTION 13 0.0035
129 LUMBAR RADICULOPATHY 4 0.0035
130 NODAL RHYTHM 5 0.0034
131 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 164 0.0034
132 PRODUCTIVE COUGH 162 0.0034
133 MACULAR OEDEMA 19 0.0034
134 BLOOD ALBUMIN INCREASED 3 0.0034
135 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 3 0.0034
136 REBOUND ACID HYPERSECRETION 10 0.0033
137 HAEMODYNAMIC INSTABILITY 25 0.0033
138 CERUMEN IMPACTION 3 0.0033
139 MYOCARDIAL ISCHAEMIA 37 0.0032
140 DIABETIC COMA 9 0.0032
141 BRADYCARDIA 168 0.0032
142 HYPOTHERMIA 32 0.0032
143 TONIC CLONIC MOVEMENTS 4 0.0031
144 WHEEZING 182 0.0031
145 SHOCK 70 0.0030
146 ATRIOVENTRICULAR BLOCK FIRST DEGREE 13 0.0030
147 METABOLIC ENCEPHALOPATHY 9 0.0030
148 RENAL TUBULAR NECROSIS 29 0.0030
149 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 26 0.0029
150 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 15 0.0029
151 BLOOD CHLORIDE INCREASED 5 0.0029
152 PUPIL FIXED 5 0.0029
153 HYPERAMMONAEMIC ENCEPHALOPATHY 5 0.0029
154 INTENTIONAL OVERDOSE 181 0.0028
155 IMPAIRED GASTRIC EMPTYING 38 0.0028
156 DIABETES MELLITUS INADEQUATE CONTROL 49 0.0028
157 OBSTRUCTIVE SLEEP APNOEA SYNDROME 4 0.0027
158 HYPOVOLAEMIA 16 0.0027
159 NORMOCYTIC ANAEMIA 4 0.0027
160 BLOOD CHLORIDE DECREASED 7 0.0027
161 BLOOD LOSS ANAEMIA 6 0.0026
162 DIABETIC NEUROPATHY 13 0.0026
163 ISCHAEMIA 12 0.0026
164 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 4 0.0026
165 PNEUMONIA PSEUDOMONAL 4 0.0026
166 CARBON DIOXIDE DECREASED 3 0.0026
167 ABSCESS LIMB 11 0.0026
168 ANURIA 22 0.0026
169 FUNGAEMIA 4 0.0025
170 THERMAL BURN 18 0.0025
171 CYSTIC FIBROSIS 14 0.0025
172 BILE DUCT STENOSIS 3 0.0025
173 BRONCHIAL HYPERREACTIVITY 3 0.0025
174 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 177 0.0025
175 PANCREATIC CARCINOMA METASTATIC 7 0.0025
176 RENAL HAEMORRHAGE 5 0.0025
177 AMPUTATION 3 0.0024
178 ACUTE RESPIRATORY FAILURE 46 0.0024
179 BRONCHIAL SECRETION RETENTION 3 0.0024
180 ADENOCARCINOMA PANCREAS 3 0.0023
181 LEFT VENTRICULAR FAILURE 8 0.0023
182 ATRIOVENTRICULAR BLOCK SECOND DEGREE 7 0.0023
183 RESPIRATORY DEPRESSION 28 0.0023
184 METHAEMOGLOBINAEMIA 5 0.0022
185 TYPE 1 DIABETES MELLITUS 13 0.0022
186 THERAPEUTIC RESPONSE DELAYED 6 0.0021
187 ACUTE KIDNEY INJURY 324 0.0021
188 CIRCULATORY COLLAPSE 36 0.0021
189 LACTIC ACIDOSIS 68 0.0021
190 LYMPHOCYTE COUNT DECREASED 37 0.0021
191 ILEUS 26 0.0021
192 SINUS BRADYCARDIA 20 0.0021
193 DIZZINESS POSTURAL 20 0.0021
194 ADRENOCORTICAL INSUFFICIENCY ACUTE 4 0.0020
195 CHRONIC KIDNEY DISEASE 153 0.0020
196 BRONCHIOLITIS 7 0.0020
197 BRAIN NATRIURETIC PEPTIDE INCREASED 6 0.0019
198 DIASTOLIC DYSFUNCTION 6 0.0019
199 OLIGURIA 12 0.0019
200 MONOCYTE COUNT INCREASED 7 0.0019
201 RED CELL DISTRIBUTION WIDTH INCREASED 8 0.0019
202 INSULIN RESISTANCE 4 0.0019
203 DIABETIC KETOACIDOSIS 46 0.0019
204 METABOLIC ACIDOSIS 61 0.0019
205 CYSTITIS INTERSTITIAL 3 0.0019
206 PROTEIN TOTAL DECREASED 7 0.0019
207 ANAL ABSCESS 10 0.0019
208 SPUTUM INCREASED 4 0.0018
209 CARDIOVASCULAR INSUFFICIENCY 3 0.0018
210 HYPERGLYCAEMIA 67 0.0018
211 BLOOD GLUCOSE FLUCTUATION 20 0.0018
212 ASTHMA 199 0.0018
213 DRUG LEVEL INCREASED 29 0.0018
214 FAILURE TO THRIVE 9 0.0017
215 ACIDOSIS 13 0.0017
216 GROWTH RETARDATION 5 0.0017
217 PANCREATITIS CHRONIC 4 0.0017
218 URINARY TRACT OBSTRUCTION 4 0.0017
219 EMBOLISM 14 0.0017
220 CYTOMEGALOVIRUS TEST POSITIVE 3 0.0017
221 RENAL TRANSPLANT 6 0.0017
222 CENTRAL VENOUS CATHETERISATION 5 0.0017
223 NEPHROGENIC SYSTEMIC FIBROSIS 5 0.0017
224 EMERGENCY CARE 5 0.0016
225 LEFT VENTRICULAR HYPERTROPHY 7 0.0016
226 INTESTINAL ISCHAEMIA 9 0.0016
227 ISCHAEMIC CARDIOMYOPATHY 5 0.0016
228 MULTIPLE ORGAN DYSFUNCTION SYNDROME 46 0.0016
229 MENTAL STATUS CHANGES 45 0.0016
230 NEPHROPATHY 15 0.0016
231 THROMBOSIS 129 0.0016
232 PULMONARY FUNCTION TEST DECREASED 7 0.0016
233 VENTRICULAR HYPERTROPHY 4 0.0016
234 SYSTEMIC CANDIDA 4 0.0016
235 VASODILATATION 4 0.0016
236 URINARY TRACT INFECTION BACTERIAL 4 0.0016
237 HYPERKALAEMIA 53 0.0015
238 ENCEPHALOPATHY 37 0.0015
239 HYPERLIPIDAEMIA 18 0.0015
240 HYPOTENSION 301 0.0015
241 EYE HAEMORRHAGE 20 0.0015
242 ASCITES 44 0.0015
243 LEUKOCYTOSIS 27 0.0015
244 DEVICE RELATED SEPSIS 3 0.0015
245 BRADYPNOEA 4 0.0015
246 SINUS TACHYCARDIA 21 0.0015
247 ACUTE RESPIRATORY DISTRESS SYNDROME 26 0.0015
248 BLOOD PHOSPHORUS INCREASED 4 0.0015
249 EUGLYCAEMIC DIABETIC KETOACIDOSIS 6 0.0015
250 PULMONARY EMBOLISM 138 0.0015
251 RED BLOOD CELL COUNT INCREASED 4 0.0014
252 EOSINOPHILIC OESOPHAGITIS 4 0.0014
253 CARDIAC ARREST 118 0.0014
254 PANCREATIC DISORDER 7 0.0014
255 SUICIDE ATTEMPT 86 0.0014
256 TOXICITY TO VARIOUS AGENTS 238 0.0014
257 CARDIOTOXICITY 12 0.0013
258 MALNUTRITION 15 0.0013
259 URINE ANALYSIS ABNORMAL 4 0.0013
260 DEPRESSED LEVEL OF CONSCIOUSNESS 52 0.0013
261 RENAL FAILURE 173 0.0013
262 RESPIRATORY FAILURE 95 0.0013
263 PIGMENTATION DISORDER 8 0.0013
264 BLOOD POTASSIUM INCREASED 21 0.0013
265 CHOLANGITIS 8 0.0013
266 RHINOVIRUS INFECTION 5 0.0013
267 ESCHERICHIA BACTERAEMIA 3 0.0013
268 VENTRICULAR TACHYCARDIA 21 0.0013
269 VENTRICULAR HYPOKINESIA 4 0.0012
270 LOOSE TOOTH 4 0.0012
271 COMA 59 0.0012
272 FACIAL PAIN 11 0.0012
273 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 5 0.0012
274 DEAFNESS NEUROSENSORY 4 0.0012
275 SEPSIS 135 0.0012
276 HYPERNATRAEMIA 6 0.0012
277 PLEURAL EFFUSION 73 0.0012
278 HYPERTRIGLYCERIDAEMIA 7 0.0012
279 OESOPHAGEAL CARCINOMA 35 0.0012
280 DIABETIC COMPLICATION 3 0.0012
281 REGURGITATION 4 0.0012
282 PULMONARY OEDEMA 52 0.0012
283 CATHETER SITE PAIN 3 0.0012
284 STAPHYLOCOCCAL BACTERAEMIA 5 0.0011
285 AORTIC STENOSIS 4 0.0011
286 DIVERTICULUM INTESTINAL 5 0.0011
287 DIALYSIS 16 0.0011
288 BLOOD POTASSIUM ABNORMAL 3 0.0011
289 AREFLEXIA 3 0.0011
290 RHINITIS ALLERGIC 5 0.0011
291 SENSORY DISTURBANCE 18 0.0011
292 TUBULOINTERSTITIAL NEPHRITIS 21 0.0011
293 HICCUPS 9 0.0011
294 UROSEPSIS 10 0.0011
295 CHOLECYSTITIS INFECTIVE 3 0.0011
296 COAGULOPATHY 18 0.0011
297 NEUTROPHIL COUNT INCREASED 11 0.0011
298 HAEMODIALYSIS 9 0.0011
299 ANGIOPATHY 6 0.0011
300 BLOOD GLUCOSE INCREASED 201 0.0011
301 CHRONIC SINUSITIS 4 0.0011
302 CHOLECYSTITIS ACUTE 6 0.0011
303 SPINAL COLUMN STENOSIS 5 0.0011
304 SEPTIC SHOCK 46 0.0011
305 RHABDOMYOLYSIS 44 0.0011
306 PSEUDOMONAS INFECTION 9 0.0010
307 RECALLED PRODUCT ADMINISTERED 10 0.0010
308 SUBCUTANEOUS ABSCESS 5 0.0010
309 ATELECTASIS 10 0.0010
310 RESPIRATORY SYNCYTIAL VIRUS INFECTION 9 0.0010
311 FLUID OVERLOAD 15 0.0010
312 URINE OUTPUT DECREASED 9 0.0010
313 PRODUCT LABEL CONFUSION 6 0.0010
314 BLOOD GLUCOSE ABNORMAL 19 0.0010
315 EPIGASTRIC DISCOMFORT 4 0.0010
316 ORAL INFECTION 4 0.0010
317 DECREASED INTEREST 6 0.0010
318 ALTERED STATE OF CONSCIOUSNESS 22 0.0010
319 BLOOD UREA INCREASED 17 0.0010
320 EXPIRED DRUG ADMINISTERED 5 0.0010
321 RENAL INJURY 30 0.0010
322 BLOOD ALBUMIN DECREASED 8 0.0010
323 GANGRENE 6 0.0010
324 ECONOMIC PROBLEM 15 0.0010
325 TOE AMPUTATION 5 0.0010
326 DYSLIPIDAEMIA 5 0.0010
327 DECUBITUS ULCER 8 0.0010
328 POLYURIA 8 0.0010
329 BRAIN DEATH 3 0.0010
330 BENIGN PROSTATIC HYPERPLASIA 5 0.0010
331 BLOOD CREATININE DECREASED 3 0.0010
332 BLOOD LACTIC ACID INCREASED 5 0.0009
333 GAMMA-GLUTAMYLTRANSFERASE INCREASED 21 0.0009
334 HYPOPHOSPHATAEMIA 7 0.0009
335 LOWER GASTROINTESTINAL HAEMORRHAGE 7 0.0009
336 ELECTROLYTE IMBALANCE 11 0.0009
337 CARDIAC FAILURE CHRONIC 4 0.0009
338 KETOACIDOSIS 7 0.0009
339 HYPOMAGNESAEMIA 13 0.0009
340 UNRESPONSIVE TO STIMULI 24 0.0009
341 BLOOD ALKALINE PHOSPHATASE INCREASED 23 0.0009
342 ATRIOVENTRICULAR BLOCK 7 0.0009
343 EXPIRED PRODUCT ADMINISTERED 30 0.0009
344 CYTOMEGALOVIRUS VIRAEMIA 4 0.0009
345 SLEEP DISORDER 63 0.0009
346 HYPOKALAEMIA 41 0.0009
347 CARDIAC FAILURE CONGESTIVE 71 0.0009
348 VASCULAR DEVICE INFECTION 4 0.0009
349 BLOOD PRESSURE SYSTOLIC DECREASED 4 0.0009
350 OBESITY 14 0.0009
351 ATRIAL FLUTTER 7 0.0009
352 GLYCOSYLATED HAEMOGLOBIN INCREASED 22 0.0009
353 LARGE INTESTINE POLYP 6 0.0009
354 UMBILICAL HERNIA 4 0.0009
355 DISSEMINATED INTRAVASCULAR COAGULATION 12 0.0009
356 CONDITION AGGRAVATED 258 0.0008
357 COVID-19 PNEUMONIA 10 0.0008
358 BACTERAEMIA 10 0.0008
359 PNEUMONIA ASPIRATION 21 0.0008
360 LOWER RESPIRATORY TRACT INFECTION 38 0.0008
361 PULMONARY CONGESTION 11 0.0008
362 ENTEROCOCCAL INFECTION 4 0.0008
363 STAPHYLOCOCCAL SEPSIS 4 0.0008
364 OVARIAN CYST 8 0.0008
365 EYE PAIN 45 0.0008
366 ANXIETY 226 0.0008
367 LUNG INFILTRATION 7 0.0008
368 TROPONIN INCREASED 6 0.0008
369 PATHOLOGICAL FRACTURE 4 0.0008
370 RENAL FAILURE CHRONIC 6 0.0008
371 INCOHERENT 5 0.0008
372 POOR QUALITY DRUG ADMINISTERED 5 0.0008
373 INTERNATIONAL NORMALISED RATIO INCREASED 22 0.0008
374 PULMONARY HYPERTENSION 16 0.0008
375 PULMONARY HAEMORRHAGE 6 0.0008
376 ELECTROCARDIOGRAM ABNORMAL 6 0.0008
377 PRODUCT ADMINISTRATION INTERRUPTED 6 0.0008
378 PNEUMONIA BACTERIAL 7 0.0008
379 RENAL IMPAIRMENT 64 0.0008
380 PULMONARY ARTERIAL HYPERTENSION 11 0.0008
381 IRON DEFICIENCY ANAEMIA 7 0.0008
382 RENAL CYST 6 0.0008
383 CLOSTRIDIUM DIFFICILE COLITIS 8 0.0008
384 CELLULITIS 38 0.0008
385 AZOTAEMIA 3 0.0008
386 HEPATIC ENCEPHALOPATHY 7 0.0007
387 SENSORY LOSS 6 0.0007
388 ENURESIS 3 0.0007
389 BLOOD SODIUM DECREASED 14 0.0007
390 BRONCHIECTASIS 5 0.0007
391 GINGIVITIS 4 0.0007
392 LOSS OF CONSCIOUSNESS 93 0.0007
393 RESPIRATORY DISTRESS 20 0.0007
394 PAIN IN EXTREMITY 212 0.0007
395 OSTEOMYELITIS 13 0.0007
396 THROMBOCYTOPENIA 80 0.0007
397 RIGHT VENTRICULAR FAILURE 5 0.0007
398 HYPONATRAEMIA 40 0.0007
399 BUNDLE BRANCH BLOCK LEFT 3 0.0007
400 PERIORBITAL SWELLING 4 0.0007
401 SUBDURAL HAEMATOMA 10 0.0007
402 BRAIN INJURY 7 0.0007
403 MULTI-ORGAN FAILURE 12 0.0007
404 PYELONEPHRITIS 6 0.0007
405 MAJOR DEPRESSION 5 0.0007
406 SPINAL OSTEOARTHRITIS 6 0.0007
407 CARDIOMYOPATHY 10 0.0007
408 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 4 0.0007
409 CARDIAC PACEMAKER INSERTION 4 0.0007
410 HYDRONEPHROSIS 5 0.0007
411 DYSPNOEA 375 0.0007
412 OSTEOPENIA 10 0.0007
413 ACUTE HEPATIC FAILURE 9 0.0007
414 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 36 0.0007
415 HAEMATOCRIT DECREASED 13 0.0007
416 SMALL INTESTINAL OBSTRUCTION 8 0.0006
417 INTERVERTEBRAL DISC DEGENERATION 6 0.0006
418 HAEMOLYSIS 5 0.0006
419 SCOLIOSIS 4 0.0006
420 OVERDOSE 139 0.0006
421 HEPATIC STEATOSIS 12 0.0006
422 DEPRESSED MOOD 34 0.0006
423 HYPOALBUMINAEMIA 5 0.0006
424 MULTIPLE INJURIES 4 0.0006
425 SPINAL DISORDER 6 0.0006
426 DRUG SCREEN POSITIVE 5 0.0006
427 VENTRICULAR FIBRILLATION 7 0.0006
428 LACRIMATION INCREASED 19 0.0006
429 SLEEP APNOEA SYNDROME 12 0.0006
430 ABSCESS 10 0.0006
431 SUPRAVENTRICULAR TACHYCARDIA 6 0.0006
432 PANCREATITIS ACUTE 14 0.0006
433 HAEMOGLOBIN ABNORMAL 4 0.0006
434 GASTROENTERITIS 9 0.0006
435 SEIZURE 71 0.0006
436 COELIAC DISEASE 6 0.0006
437 BREATH SOUNDS ABNORMAL 3 0.0006
438 ESCHERICHIA INFECTION 5 0.0006
439 TACHYCARDIA 54 0.0006
440 HOSPICE CARE 6 0.0006
441 ACUTE CORONARY SYNDROME 5 0.0006
442 ALANINE AMINOTRANSFERASE INCREASED 37 0.0006
443 CARDIAC FAILURE ACUTE 4 0.0006
444 LEFT VENTRICULAR DYSFUNCTION 4 0.0006
445 POST-TRAUMATIC STRESS DISORDER 4 0.0006
446 CORONARY ARTERY STENOSIS 3 0.0006
447 PERITONITIS BACTERIAL 6 0.0006
448 DRUG TOLERANCE 3 0.0006
449 COLITIS ISCHAEMIC 4 0.0006
450 EYE MOVEMENT DISORDER 4 0.0006
451 SYNCOPE 58 0.0006
452 TENDERNESS 6 0.0006
453 DRUG INTERACTION 91 0.0006
454 CYTOPENIA 7 0.0006
455 PNEUMONIA 184 0.0006
456 INCONTINENCE 6 0.0006
457 NEPHROLITHIASIS 26 0.0006
458 BLOOD POTASSIUM DECREASED 17 0.0006
459 BLINDNESS 23 0.0006
460 HAEMORRHOIDS 11 0.0006
461 WRONG DRUG ADMINISTERED 5 0.0006
462 OEDEMA 30 0.0006
463 LIMB INJURY 15 0.0006
464 SKIN LACERATION 6 0.0006
465 CARDIO-RESPIRATORY ARREST 23 0.0005
466 CYTOKINE RELEASE SYNDROME 11 0.0005
467 ASTHENOPIA 3 0.0005
468 STAPHYLOCOCCAL INFECTION 18 0.0005
469 SWELLING 51 0.0005
470 SKIN ULCER 14 0.0005
471 FISTULA 6 0.0005
472 ANHEDONIA 14 0.0005
473 CEREBRAL INFARCTION 13 0.0005
474 HEPATIC FAILURE 16 0.0005
475 ELECTROCARDIOGRAM QT PROLONGED 19 0.0005
476 TOXIC EPIDERMAL NECROLYSIS 8 0.0005
477 DYSPHAGIA 50 0.0005
478 DIABETES MELLITUS 40 0.0005
479 ATRIAL FIBRILLATION 51 0.0005
480 LIPASE INCREASED 4 0.0005
481 SKIN EXFOLIATION 44 0.0005
482 BLOOD BILIRUBIN INCREASED 14 0.0005
483 TACHYPNOEA 7 0.0005
484 APNOEA 4 0.0005
485 VITAMIN D DEFICIENCY 5 0.0005
486 FEBRILE NEUTROPENIA 34 0.0005
487 PANCREATITIS 27 0.0005
488 NO ADVERSE EVENT 92 0.0005
489 BLOOD CREATININE INCREASED 33 0.0005
490 CYSTITIS 16 0.0005
491 DEHYDRATION 67 0.0005
492 BURNING SENSATION 35 0.0005
493 GASTROENTERITIS VIRAL 9 0.0005
494 CORONARY ARTERY DISEASE 15 0.0005
495 RENAL FAILURE ACUTE 21 0.0005
496 MUSCLE DISORDER 4 0.0005
497 POST PROCEDURAL INFECTION 4 0.0005
498 SHOCK HAEMORRHAGIC 4 0.0005
499 ANAPHYLACTIC REACTION 27 0.0005
500 GLOMERULAR FILTRATION RATE DECREASED 6 0.0005
501 CHOLELITHIASIS 16 0.0005
502 UPPER-AIRWAY COUGH SYNDROME 4 0.0005
503 SPINAL COMPRESSION FRACTURE 4 0.0005
504 POOR VENOUS ACCESS 5 0.0005
505 HEPATIC CIRRHOSIS 9 0.0005
506 HYPOCALCAEMIA 9 0.0005
507 VOMITING 223 0.0005
508 PULMONARY MASS 7 0.0005
509 ENTERITIS 3 0.0005
510 ROTATOR CUFF SYNDROME 6 0.0005
511 HIP FRACTURE 15 0.0005
512 BREAST CANCER METASTATIC 5 0.0005
513 BLOOD MAGNESIUM DECREASED 4 0.0005
514 HIATUS HERNIA 6 0.0005
515 MUSCLE STRAIN 4 0.0005
516 HYSTERECTOMY 4 0.0005
517 PRODUCT PRESCRIBING ISSUE 10 0.0005
518 INSURANCE ISSUE 7 0.0005
519 DEVICE RELATED INFECTION 7 0.0005
520 BLOOD TRIGLYCERIDES INCREASED 8 0.0005
521 URINARY TRACT INFECTION 77 0.0005
522 RESPIRATORY RATE INCREASED 4 0.0005
523 EJECTION FRACTION DECREASED 7 0.0004
524 HYPERTENSIVE CRISIS 5 0.0004
525 DEEP VEIN THROMBOSIS 29 0.0004
526 MYOSITIS 4 0.0004
527 SWELLING FACE 29 0.0004
528 PRODUCT ADMINISTRATION ERROR 9 0.0004
529 BLOOD CALCIUM DECREASED 5 0.0004
530 SINUS CONGESTION 6 0.0004
531 STATUS EPILEPTICUS 5 0.0004
532 HEAD INJURY 14 0.0004
533 ACUTE MYOCARDIAL INFARCTION 13 0.0004
534 PNEUMONITIS 12 0.0004
535 RESPIRATORY TRACT CONGESTION 7 0.0004
536 ACCIDENTAL OVERDOSE 16 0.0004
537 GRAND MAL CONVULSION 4 0.0004
538 PERICARDIAL EFFUSION 10 0.0004
539 GASTROINTESTINAL HAEMORRHAGE 36 0.0004
540 HYPOPHAGIA 11 0.0004
541 DIARRHOEA HAEMORRHAGIC 4 0.0004
542 ANAPHYLACTIC SHOCK 11 0.0004
543 DUODENAL ULCER 3 0.0004
544 SQUAMOUS CELL CARCINOMA 4 0.0004
545 DYSPNOEA EXERTIONAL 16 0.0004
546 CHOLECYSTITIS 5 0.0004
547 HAEMOGLOBIN DECREASED 43 0.0004
548 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 3 0.0004
549 LETHARGY 24 0.0004
550 WHITE BLOOD CELL COUNT INCREASED 16 0.0004
551 UPPER GASTROINTESTINAL HAEMORRHAGE 7 0.0004
552 HYPERTHYROIDISM 6 0.0004
553 COUGH 116 0.0004
554 OSTEOPOROSIS 17 0.0004
555 COMPLICATION ASSOCIATED WITH DEVICE 6 0.0004
556 ADRENAL INSUFFICIENCY 5 0.0004
557 NEURALGIA 10 0.0004
558 SPINAL OPERATION 5 0.0004
559 ARRHYTHMIA 19 0.0004
560 GASTROOESOPHAGEAL REFLUX DISEASE 32 0.0004
561 BRAIN OEDEMA 5 0.0004
562 TOOTH ABSCESS 4 0.0004
563 SUBARACHNOID HAEMORRHAGE 4 0.0004
564 BOWEL MOVEMENT IRREGULARITY 3 0.0004
565 HOSPITALISATION 60 0.0004
566 UPPER RESPIRATORY TRACT INFECTION 18 0.0004
567 PAIN IN JAW 11 0.0004
568 MUSCULOSKELETAL CHEST PAIN 6 0.0004
569 TEMPERATURE INTOLERANCE 4 0.0004
570 BRONCHOPULMONARY ASPERGILLOSIS 3 0.0004
571 APHTHOUS ULCER 3 0.0004
572 LUNG INFECTION 6 0.0004
573 TYPE 2 DIABETES MELLITUS 13 0.0004
574 PHARMACEUTICAL PRODUCT COMPLAINT 10 0.0004
575 RESTLESS LEGS SYNDROME 7 0.0004
576 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 20 0.0004
577 TRANSFUSION 4 0.0004
578 THERAPY NON-RESPONDER 17 0.0004
579 SCIATICA 6 0.0004
580 EYE SWELLING 14 0.0004
581 BLOOD PRESSURE DECREASED 25 0.0004
582 BLOOD DISORDER 3 0.0004
583 FOOT FRACTURE 7 0.0004
584 OEDEMA PERIPHERAL 45 0.0004
585 OESOPHAGITIS 4 0.0004
586 SEROTONIN SYNDROME 7 0.0004
587 RESPIRATORY ARREST 10 0.0004
588 NERVE INJURY 4 0.0004
589 DEMENTIA 10 0.0004
590 MASS 5 0.0004
591 SNEEZING 8 0.0004
592 PLATELET COUNT DECREASED 38 0.0004
593 CANDIDA INFECTION 6 0.0004
594 SEASONAL ALLERGY 5 0.0004
595 DERMATITIS CONTACT 4 0.0004
596 MICTURITION URGENCY 4 0.0003
597 INTERNAL HAEMORRHAGE 4 0.0003
598 RED BLOOD CELL COUNT DECREASED 10 0.0003
599 CONVULSION 20 0.0003
600 CARDIAC FAILURE 28 0.0003
601 ACCIDENTAL UNDERDOSE 5 0.0003
602 CARDIAC MURMUR 3 0.0003
603 TASTE DISORDER 7 0.0003
604 MENTAL DISORDER 15 0.0003
605 ORTHOSTATIC HYPOTENSION 6 0.0003
606 COLITIS 13 0.0003
607 GASTRITIS 9 0.0003
608 HEART RATE DECREASED 12 0.0003
609 SPLENOMEGALY 4 0.0003
610 ASPARTATE AMINOTRANSFERASE INCREASED 18 0.0003
611 OXYGEN SATURATION DECREASED 19 0.0003
612 PERITONITIS 7 0.0003
613 NEUROPATHY PERIPHERAL 32 0.0003
614 HAEMORRHAGE INTRACRANIAL 5 0.0003
615 HALLUCINATION, VISUAL 7 0.0003
616 TOOTHACHE 6 0.0003
617 VISUAL IMPAIRMENT 41 0.0003
618 NOCTURIA 4 0.0003
619 CHEST PAIN 61 0.0003
620 BONE DISORDER 6 0.0003
621 PRESYNCOPE 8 0.0003
622 DYSURIA 12 0.0003
623 ANAEMIA 62 0.0003
624 FALL 108 0.0003
625 HYPERCALCAEMIA 4 0.0003
626 PYREXIA 112 0.0003
627 GENERALISED OEDEMA 4 0.0003
628 ABDOMINAL PAIN 75 0.0003
629 EXTRAPYRAMIDAL DISORDER 8 0.0003
630 PANCYTOPENIA 18 0.0003
631 WOUND 9 0.0003
632 CLOSTRIDIUM DIFFICILE INFECTION 7 0.0003
633 HYPERHIDROSIS 41 0.0003
634 DERMATITIS ALLERGIC 4 0.0003
635 MUSCLE ATROPHY 4 0.0003
636 PROTEINURIA 6 0.0003
637 PNEUMOTHORAX 5 0.0003
638 ULCER 5 0.0003
639 THROAT IRRITATION 14 0.0003
640 POLLAKIURIA 13 0.0003
641 PANCREATIC CARCINOMA 9 0.0003
642 INFECTION 45 0.0003
643 TREATMENT NONCOMPLIANCE 17 0.0003
644 RHINORRHOEA 20 0.0003
645 HAEMATOMA 8 0.0003
646 EAR PAIN 6 0.0003
647 AUTOIMMUNE DISORDER 3 0.0003
648 CHOKING 6 0.0003
649 CEREBRAL HAEMORRHAGE 11 0.0003
650 OSTEOARTHRITIS 13 0.0003
651 DEAFNESS 8 0.0003
652 PERIPHERAL SWELLING 47 0.0003
653 LABORATORY TEST ABNORMAL 9 0.0003
654 MULTIPLE FRACTURES 5 0.0003
655 NECK PAIN 17 0.0003
656 CONFUSIONAL STATE 49 0.0003
657 SINUS DISORDER 6 0.0003
658 BLOOD PRESSURE ABNORMAL 6 0.0003
659 HEADACHE 189 0.0003
660 CYTOMEGALOVIRUS INFECTION 5 0.0003
661 NAUSEA 238 0.0003
662 FUNGAL INFECTION 10 0.0003
663 GAIT INABILITY 10 0.0003
664 CONSTIPATION 65 0.0003
665 EMPHYSEMA 3 0.0003
666 TRANSIENT ISCHAEMIC ATTACK 10 0.0003
667 DRUG INEFFECTIVE 389 0.0003
668 BODY TEMPERATURE INCREASED 6 0.0003
669 PALLOR 8 0.0003
670 DRUG TOXICITY 4 0.0003
671 LIVER DISORDER 13 0.0003
672 EAR DISCOMFORT 3 0.0003
673 SCAR 5 0.0003
674 INTESTINAL OBSTRUCTION 11 0.0003
675 RIB FRACTURE 6 0.0003
676 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 5 0.0003
677 MUSCULAR WEAKNESS 33 0.0003
678 LOCALISED INFECTION 7 0.0003
679 ORAL DISCOMFORT 4 0.0003
680 UNDERDOSE 21 0.0003
681 NEUROTOXICITY 5 0.0003
682 DIZZINESS 142 0.0003
683 BLOOD TEST ABNORMAL 4 0.0003
684 ASTHENIA 107 0.0003
685 INJURY 20 0.0003
686 BLINDNESS UNILATERAL 4 0.0003
687 MALAISE 124 0.0003
688 HEAD DISCOMFORT 5 0.0003
689 THIRST 5 0.0003
690 PARALYSIS 4 0.0003
691 ANGINA PECTORIS 8 0.0003
692 SOMNOLENCE 56 0.0003
693 BLOOD CREATINE PHOSPHOKINASE INCREASED 8 0.0003
694 VISION BLURRED 38 0.0003
695 MYELODYSPLASTIC SYNDROME 4 0.0003
696 ANOSMIA 4 0.0003
697 HAEMATEMESIS 7 0.0003
698 BIPOLAR DISORDER 3 0.0003
699 LIVER FUNCTION TEST ABNORMAL 8 0.0003
700 NEEDLE ISSUE 8 0.0003
701 IMPAIRED HEALING 9 0.0003
702 HYPOAESTHESIA 41 0.0003
703 ASPIRATION 3 0.0003
704 MELAENA 6 0.0003
705 APPLICATION SITE PAIN 6 0.0003
706 INCORRECT DOSE ADMINISTERED 62 0.0003
707 EXTRA DOSE ADMINISTERED 11 0.0003
708 DENTAL CARIES 3 0.0003
709 DYSKINESIA 11 0.0003
710 URINARY INCONTINENCE 8 0.0003
711 URINARY RETENTION 9 0.0003
712 DIPLOPIA 7 0.0003
713 THINKING ABNORMAL 5 0.0003
714 EYE PRURITUS 9 0.0003
715 SPEECH DISORDER 14 0.0003
716 DYSARTHRIA 10 0.0003
717 PRODUCT DOSE OMISSION ISSUE 78 0.0003
718 SKIN BURNING SENSATION 19 0.0003
719 COMPLETED SUICIDE 22 0.0003
720 HEART RATE INCREASED 26 0.0003
721 BLOOD PRESSURE INCREASED 40 0.0003
722 PRODUCT DOSE OMISSION 17 0.0003
723 POST PROCEDURAL COMPLICATION 5 0.0003
724 LOWER LIMB FRACTURE 5 0.0003
725 GLAUCOMA 5 0.0003
726 THYROID DISORDER 4 0.0003
727 EMOTIONAL DISORDER 8 0.0003
728 DELIRIUM 9 0.0003
729 LYMPHOMA 4 0.0003
730 NEOPLASM PROGRESSION 9 0.0003
731 ANKLE FRACTURE 4 0.0003
732 ABDOMINAL PAIN UPPER 53 0.0003
733 ACUTE MYELOID LEUKAEMIA 4 0.0003
734 BLOOD PRESSURE SYSTOLIC INCREASED 5 0.0003
735 NERVOUS SYSTEM DISORDER 8 0.0003
736 PLASMA CELL MYELOMA 10 0.0003
737 RECTAL HAEMORRHAGE 11 0.0003
738 DRUG DOSE OMISSION BY DEVICE 20 0.0003
739 NASAL CONGESTION 15 0.0003
740 KIDNEY INFECTION 5 0.0003
741 DECREASED APPETITE 59 0.0003
742 EPISTAXIS 19 0.0003
743 PROCEDURAL PAIN 7 0.0003
744 MIGRAINE 24 0.0003
745 GENERAL PHYSICAL HEALTH DETERIORATION 29 0.0003
746 DEATH 215 0.0002
747 ABDOMINAL DISTENSION 26 0.0002
748 INTENTIONAL DOSE OMISSION 7 0.0002
749 INJURY ASSOCIATED WITH DEVICE 5 0.0002
750 NEUTROPHIL COUNT DECREASED 10 0.0002
751 CEREBROVASCULAR ACCIDENT 41 0.0002
752 DRY EYE 12 0.0002
753 VIRAL INFECTION 8 0.0002
754 GAIT DISTURBANCE 46 0.0002
755 DIARRHOEA 153 0.0002
756 WEIGHT DECREASED 66 0.0002
757 CARDIOVASCULAR DISORDER 6 0.0002
758 HEMIPARESIS 4 0.0002
759 RENAL DISORDER 11 0.0002
760 HYPERTENSION 50 0.0002
761 OFF LABEL USE 206 0.0002
762 PARAESTHESIA 37 0.0002
763 MYOCARDIAL INFARCTION 41 0.0002
764 JOINT INJURY 5 0.0002
765 RESPIRATORY DISORDER 7 0.0002
766 DYSPEPSIA 23 0.0002
767 IRRITABLE BOWEL SYNDROME 5 0.0002
768 DEPRESSION 53 0.0002
769 LIVER FUNCTION TEST INCREASED 5 0.0002
770 BACK PAIN 54 0.0002
771 POOR QUALITY SLEEP 5 0.0002
772 APHASIA 7 0.0002
773 FAECES DISCOLOURED 5 0.0002
774 RESPIRATORY TRACT INFECTION 6 0.0002
775 SYRINGE ISSUE 4 0.0002
776 DRUG ADMINISTRATION ERROR 7 0.0002
777 METASTASES TO LIVER 4 0.0002
778 DISORIENTATION 9 0.0002
779 COLD SWEAT 4 0.0002
780 EAR INFECTION 6 0.0002
781 GALLBLADDER DISORDER 4 0.0002
782 GOUT 4 0.0002
783 CHROMATURIA 5 0.0002
784 CORONARY ARTERY OCCLUSION 3 0.0002
785 CATARACT 13 0.0002
786 NIGHT SWEATS 7 0.0002
787 FLUID RETENTION 11 0.0002
788 MEDICATION ERROR 12 0.0002
789 COORDINATION ABNORMAL 3 0.0002
790 BACTERIAL INFECTION 4 0.0002
791 CARPAL TUNNEL SYNDROME 3 0.0002
792 DEVICE OCCLUSION 3 0.0002
793 EYE DISORDER 7 0.0002
794 TARDIVE DYSKINESIA 6 0.0002
795 UNEVALUABLE EVENT 16 0.0002
796 OCULAR HYPERAEMIA 10 0.0002
797 BRONCHOSPASM 3 0.0002
798 PRODUCT PRESCRIBING ERROR 5 0.0002
799 FEELING JITTERY 4 0.0002
800 HYPERSOMNIA 6 0.0002
801 HYPOACUSIS 9 0.0002
802 EYE IRRITATION 12 0.0002
803 CONTUSION 20 0.0002
804 ERUCTATION 4 0.0002
805 MENTAL IMPAIRMENT 5 0.0002
806 INFLUENZA 23 0.0002
807 COVID-19 36 0.0002
808 CHEST DISCOMFORT 21 0.0002
809 HAEMATURIA 7 0.0002
810 AGITATION 15 0.0002
811 INJECTION SITE URTICARIA 5 0.0002
812 PSYCHOTIC DISORDER 6 0.0002
813 OSTEONECROSIS OF JAW 5 0.0002
814 PRODUCT USE IN UNAPPROVED INDICATION 50 0.0002
815 COLON CANCER 3 0.0002
816 GASTROINTESTINAL DISORDER 18 0.0002
817 AGEUSIA 5 0.0002
818 AGGRESSION 10 0.0002
819 EMOTIONAL DISTRESS 24 0.0002
820 BLOOD COUNT ABNORMAL 3 0.0002
821 FATIGUE 154 0.0002
822 ABDOMINAL PAIN LOWER 5 0.0002
823 DEVICE FAILURE 3 0.0002
824 VERTIGO 12 0.0002
825 BALANCE DISORDER 17 0.0002
826 DRUG DISPENSING ERROR 3 0.0002
827 CHILLS 23 0.0002
828 MUSCLE SPASMS 36 0.0002
829 FEELING HOT 12 0.0002
830 HEPATITIS 5 0.0002
831 RASH 85 0.0002
832 INFLUENZA LIKE ILLNESS 16 0.0002
833 INTENTIONAL PRODUCT MISUSE 17 0.0002
834 TOOTH LOSS 4 0.0002
835 COGNITIVE DISORDER 9 0.0002
836 CARDIAC DISORDER 18 0.0002
837 PANIC ATTACK 7 0.0002
838 DERMATITIS 4 0.0002
839 MUSCULOSKELETAL PAIN 10 0.0002
840 PAIN 117 0.0002
841 DYSPHONIA 11 0.0002
842 EATING DISORDER 4 0.0002
843 FEAR 5 0.0002
844 JAUNDICE 5 0.0002
845 SKIN CANCER 4 0.0002
846 THROAT TIGHTNESS 5 0.0002
847 INTERVERTEBRAL DISC PROTRUSION 4 0.0002
848 DEVICE DELIVERY SYSTEM ISSUE 5 0.0002
849 THERAPEUTIC RESPONSE DECREASED 11 0.0002
850 HAEMATOCHEZIA 10 0.0002
851 VISUAL ACUITY REDUCED 6 0.0002
852 DIVERTICULITIS 5 0.0002
853 TOOTH DISORDER 4 0.0002
854 NEOPLASM MALIGNANT 12 0.0002
855 HEPATOTOXICITY 4 0.0002
856 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 6 0.0002
857 HEART RATE IRREGULAR 4 0.0002
858 HEPATIC ENZYME INCREASED 12 0.0002
859 MALIGNANT NEOPLASM PROGRESSION 18 0.0002
860 MEMORY IMPAIRMENT 24 0.0002
861 TINNITUS 8 0.0002
862 MUSCLE TWITCHING 4 0.0002
863 OROPHARYNGEAL PAIN 16 0.0002
864 DRY MOUTH 14 0.0002
865 BLOOD CHOLESTEROL INCREASED 8 0.0002
866 PALPITATIONS 20 0.0002
867 SURGERY 10 0.0002
868 LUNG NEOPLASM MALIGNANT 7 0.0002
869 NEUTROPENIA 23 0.0002
870 PSORIASIS 22 0.0002
871 WHITE BLOOD CELL COUNT DECREASED 18 0.0002
872 WRONG TECHNIQUE IN DRUG USAGE PROCESS 6 0.0002
873 ILLNESS 17 0.0002
874 FIBROMYALGIA 4 0.0002
875 BRONCHITIS 12 0.0002
876 ABASIA 4 0.0002
877 LEUKOPENIA 8 0.0002
878 BONE DENSITY DECREASED 5 0.0002
879 HOT FLUSH 12 0.0002
880 BLOOD URINE PRESENT 3 0.0002
881 GASTRIC CANCER 4 0.0002
882 TREATMENT FAILURE 13 0.0002
883 HERPES ZOSTER 9 0.0002
884 THERAPEUTIC PRODUCT EFFECT DECREASED 7 0.0002
885 DRUG PRESCRIBING ERROR 3 0.0002
886 SINUSITIS 16 0.0002
887 URTICARIA 26 0.0002
888 ABDOMINAL DISCOMFORT 26 0.0002
889 FEELING ABNORMAL 37 0.0002
890 THERAPY INTERRUPTED 11 0.0002
891 NERVOUSNESS 8 0.0002
892 DISEASE PROGRESSION 18 0.0002
893 DISABILITY 3 0.0002
894 ACTIVITIES OF DAILY LIVING IMPAIRED 3 0.0002
895 ERYTHEMA 31 0.0002
896 COMPLICATION OF DEVICE INSERTION 3 0.0002
897 TREMOR 25 0.0002
898 INSOMNIA 40 0.0002
899 LIP SWELLING 5 0.0001
900 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 7 0.0001
901 DISTURBANCE IN ATTENTION 8 0.0001
902 ILL-DEFINED DISORDER 9 0.0001
903 FREQUENT BOWEL MOVEMENTS 4 0.0001
904 RASH PRURITIC 8 0.0001
905 FLUSHING 15 0.0001
906 MOOD ALTERED 4 0.0001
907 RASH ERYTHEMATOUS 7 0.0001
908 SKIN LESION 4 0.0001
909 ADVERSE DRUG REACTION 13 0.0001
910 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 26 0.0001
911 ARTHROPATHY 8 0.0001
912 INCORRECT DRUG ADMINISTRATION DURATION 4 0.0001
913 SUICIDAL IDEATION 13 0.0001
914 LYMPHADENOPATHY 5 0.0001
915 MYELOSUPPRESSION 5 0.0001
916 AMNESIA 9 0.0001
917 VAGINAL HAEMORRHAGE 6 0.0001
918 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 28 0.0001
919 DYSSTASIA 4 0.0001
920 BONE PAIN 8 0.0001
921 PREMATURE BABY 4 0.0001
922 EPILEPSY 4 0.0001
923 INJECTION SITE REACTION 9 0.0001
924 MOBILITY DECREASED 9 0.0001
925 BLISTER 7 0.0001
926 MYALGIA 21 0.0001
927 FLATULENCE 7 0.0001
928 WEIGHT INCREASED 27 0.0001
929 ROAD TRAFFIC ACCIDENT 5 0.0001
930 INJECTION SITE PRURITUS 8 0.0001
931 ADVERSE EVENT 11 0.0001
932 HYPERSENSITIVITY 22 0.0001
933 ANGER 4 0.0001
934 ERECTILE DYSFUNCTION 3 0.0001
935 INFLAMMATION 6 0.0001
936 INTENTIONAL PRODUCT USE ISSUE 10 0.0001
937 EXPOSURE DURING PREGNANCY 7 0.0001
938 PRODUCT USE ISSUE 21 0.0001
939 DEVICE ISSUE 10 0.0001
940 THERAPEUTIC RESPONSE UNEXPECTED 5 0.0001
941 C-REACTIVE PROTEIN INCREASED 4 0.0001
942 HALLUCINATION 8 0.0001
943 ARTHRALGIA 44 0.0001
944 HAEMORRHAGE 11 0.0001
945 NASOPHARYNGITIS 19 0.0001
946 PRODUCT QUALITY ISSUE 14 0.0001
947 MULTIPLE SCLEROSIS RELAPSE 7 0.0001
948 INJECTION SITE PAIN 31 0.0001
949 ABNORMAL BEHAVIOUR 4 0.0001
950 INJECTION SITE BRUISING 8 0.0001
951 IRRITABILITY 6 0.0001
952 CONTRAINDICATED PRODUCT ADMINISTERED 3 0.0001
953 STOMATITIS 6 0.0001
954 PSORIATIC ARTHROPATHY 4 0.0001
955 THERAPY CESSATION 5 0.0001
956 DRUG-INDUCED LIVER INJURY 3 0.0001
957 DYSGEUSIA 7 0.0001
958 DEVICE DISLOCATION 4 0.0001
959 DRUG DOSE OMISSION 15 0.0001
960 MATERNAL EXPOSURE DURING PREGNANCY 8 0.0001
961 DRUG EXPOSURE DURING PREGNANCY 3 0.0001
962 SKIN DISCOLOURATION 4 0.0001
963 PROSTATE CANCER 7 0.0001
964 PRURITUS 32 0.0001
965 JOINT SWELLING 10 0.0001
966 DRUG INTOLERANCE 8 0.0001
967 INTERSTITIAL LUNG DISEASE 4 0.0001
968 CRYING 3 0.0001
969 DISCOMFORT 5 0.0001
970 INFUSION RELATED REACTION 5 0.0001
971 DEVICE MALFUNCTION 5 0.0001
972 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 5 0.0001
973 DRUG WITHDRAWAL SYNDROME 6 0.0001
974 ACNE 5 0.0001
975 ARTHRITIS 5 0.0001
976 INJECTION SITE HAEMORRHAGE 5 0.0001
977 ALOPECIA 12 0.0001
978 DEVICE DIFFICULT TO USE 4 0.0001
979 ACCIDENTAL EXPOSURE TO PRODUCT 6 0.0001
980 ECZEMA 3 0.0001
981 PRODUCT STORAGE ERROR 5 0.0001
982 DERMATITIS ATOPIC 3 0.0001
983 INJECTION SITE SWELLING 4 0.0001
984 BLADDER CANCER 3 0.0001
985 FOETAL EXPOSURE DURING PREGNANCY 4 0.0000
986 DRUG ABUSE 4 0.0000
987 MUSCULOSKELETAL STIFFNESS 4 0.0000
988 DRUG DEPENDENCE 7 0.0000
989 INJECTION SITE ERYTHEMA 5 0.0000
990 DRY SKIN 4 0.0000